EP1368061 - FUSION CELLS AND CYTOKINE COMPOSITIONS FOR TREATMENT OF DISEASE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 30.10.2009 Database last updated on 24.08.2024 | Most recent event Tooltip | 30.09.2011 | Lapse of the patent in a contracting state New state(s): CY, TR | published on 02.11.2011 [2011/44] | Applicant(s) | For all designated states OHNO, Tsuneya 201 Newbury Street no 206 Boston, MA 02116 / US | [2008/52] |
Former [2003/50] | For all designated states Ohno, Tsuneya 201 Newbury Street no 206 Boston, MA 02116 / US | Inventor(s) | 01 /
see applicant ... | [2003/50] | Representative(s) | Chapman, Paul Gilmour, et al Marks & Clerk LLP The Beacon 176 St Vincent Street Glasgow G2 5SG / GB | [N/P] |
Former [2003/50] | Chapman, Paul Gilmour, et al Cruikshank & Fairweather, 19 Royal Exchange Square Glasgow G1 3AE / GB | Application number, filing date | 01987655.6 | 22.10.2001 | [2003/50] | WO2001US47057 | Priority number, date | US20000242154P | 20.10.2000 Original published format: US 242154 P | [2003/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0232378 | Date: | 25.04.2002 | Language: | EN | [2002/17] | Type: | A2 Application without search report | No.: | EP1368061 | Date: | 10.12.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.04.2002 takes the place of the publication of the European patent application. | [2003/50] | Type: | B1 Patent specification | No.: | EP1368061 | Date: | 24.12.2008 | Language: | EN | [2008/52] | Search report(s) | International search report - published on: | US | 27.02.2003 | (Supplementary) European search report - dispatched on: | EP | 05.09.2005 | Classification | IPC: | A61K45/00, A61K47/00, A01N63/00, C12N5/00, C12N5/06, C12N5/12 | [2003/50] | CPC: |
C12N5/16 (EP,US);
A61K39/0011 (US);
A61K39/4615 (EP);
A61K39/4622 (EP);
A61K39/464499 (EP);
A61P31/00 (EP);
A61P31/12 (EP);
A61P31/16 (EP);
A61P31/18 (EP);
A61P31/22 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61K2039/5152 (US);
A61K2039/5154 (US);
A61K2039/5156 (US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/50] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | FUSIONSZELLEN UND ZYTOKIN-ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON KRANKHEITEN | [2003/50] | English: | FUSION CELLS AND CYTOKINE COMPOSITIONS FOR TREATMENT OF DISEASE | [2003/50] | French: | CELLULES DE FUSION ET COMPOSITIONS CYTOKINIQUES POUR LE TRAITEMENT DE MALADIES | [2003/50] | Entry into regional phase | 16.05.2003 | National basic fee paid | 16.05.2003 | Search fee paid | 16.05.2003 | Designation fee(s) paid | 16.05.2003 | Examination fee paid | Examination procedure | 14.05.2002 | Request for preliminary examination filed International Preliminary Examining Authority: US | 16.05.2003 | Examination requested [2003/50] | 17.11.2003 | Amendment by applicant (claims and/or description) | 14.11.2005 | Despatch of a communication from the examining division (Time limit: M06) | 11.05.2006 | Reply to a communication from the examining division | 10.03.2008 | Cancellation of oral proceeding that was planned for 14.03.2008 | 10.03.2008 | Minutes of oral proceedings despatched | 14.03.2008 | Date of oral proceedings | 14.03.2008 | Date of oral proceedings (cancelled) | 18.06.2008 | Communication of intention to grant the patent | 24.10.2008 | Fee for grant paid | 24.10.2008 | Fee for publishing/printing paid | Opposition(s) | 25.09.2009 | No opposition filed within time limit [2009/49] | Fees paid | Renewal fee | 28.10.2003 | Renewal fee patent year 03 | 26.10.2004 | Renewal fee patent year 04 | 26.10.2005 | Renewal fee patent year 05 | 26.10.2006 | Renewal fee patent year 06 | 23.04.2008 | Renewal fee patent year 07 | 14.10.2008 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.10.2007 | 07   M06   Fee paid on   23.04.2008 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 24.12.2008 | BE | 24.12.2008 | CY | 24.12.2008 | DK | 24.12.2008 | FI | 24.12.2008 | NL | 24.12.2008 | TR | 24.12.2008 | SE | 24.03.2009 | GR | 25.03.2009 | ES | 04.04.2009 | PT | 25.05.2009 | [2011/43] |
Former [2010/47] | AT | 24.12.2008 | |
BE | 24.12.2008 | ||
DK | 24.12.2008 | ||
FI | 24.12.2008 | ||
NL | 24.12.2008 | ||
SE | 24.03.2009 | ||
GR | 25.03.2009 | ||
ES | 04.04.2009 | ||
PT | 25.05.2009 | ||
Former [2009/46] | AT | 24.12.2008 | |
BE | 24.12.2008 | ||
DK | 24.12.2008 | ||
FI | 24.12.2008 | ||
NL | 24.12.2008 | ||
SE | 24.03.2009 | ||
ES | 04.04.2009 | ||
PT | 25.05.2009 | ||
Former [2009/40] | AT | 24.12.2008 | |
BE | 24.12.2008 | ||
FI | 24.12.2008 | ||
NL | 24.12.2008 | ||
SE | 24.03.2009 | ||
ES | 04.04.2009 | ||
PT | 25.05.2009 | ||
Former [2009/37] | BE | 24.12.2008 | |
FI | 24.12.2008 | ||
NL | 24.12.2008 | ||
SE | 24.03.2009 | ||
ES | 04.04.2009 | ||
PT | 25.05.2009 | ||
Former [2009/33] | BE | 24.12.2008 | |
FI | 24.12.2008 | ||
NL | 24.12.2008 | ||
ES | 04.04.2009 | ||
Former [2009/32] | BE | 24.12.2008 | |
FI | 24.12.2008 | ||
NL | 24.12.2008 | ||
Former [2009/25] | FI | 24.12.2008 | |
NL | 24.12.2008 | Documents cited: | Search | [X]DE19633731 (PETERS JOHANN HINRICH PROF DR [DE]) [X] 1-3,5-12,18,21,26,29-32,34-37,39,41-44,48-50 * the whole document *; | [XY]WO9846785 (DANA FARBER CANCER INST INC [US]) [X] 1-3,5-8,10,14,18,26,29-31,35,36,39-41,48-50 * the whole document * [Y] 4,19,20,22,27,28; | [PX]WO0162902 (UNIV EBERHARD KARLS [DE]) [PX] 1-18,21,24-26,29-50* the whole document *; | [X] - CAO X ET AL, THERAPY OF ESTABLISHED TUMOUR WITH A HYBRID CELLULAR VACCINE GENERATED BY USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENETICALLY MODIFIED DENDRITIC CELLS, IMMUNOLOGY, BLACKWELL SCIENTIFIC PUBLICATIONS, GB, PAGE(S) 616-625, (1999), ISSN 0019-2805, XP002950172 [X] 1 * the whole document * DOI: http://dx.doi.org/10.1046/j.1365-2567.1999.00823.x | [X] - WANG J ET AL, Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines, JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, PAGE(S) 5516-5524, (1998), ISSN 0022-1767, XP002171426 [X] 1 * the whole document * | [Y] - FALLARINO F ET AL, "IMPROVED EFFICACY OF DENDRITIC CELL VACCINES AND SUCCESSFUL IMMUNIZATION WITH TUMOR ANTIGEN PEPTIDE-PULSED PERIPHERAL BLOOD MONONUCLEAR CELLS BY COADMINISTRATION OF RECOMBINANT MURINE INTERLEUKIN-12", INTERNATIONAL JOURNAL OF CANCER, NEW YORK, NY, US, (19990118), vol. 80, no. 2, ISSN 0020-7136, pages 324 - 333, XP000867038 [Y] 4,19,20,22,27,28 * the whole document * DOI: http://dx.doi.org/10.1002/(SICI)1097-0215(19990118)80:2<324::AID-IJC25>3.0.CO;2-D | International search | [Y] - LESPAGNARD, L. ET AL., "Dendritic cells fused with mastocytoma cells elicit therapeutic antitumor immunity", INT. J. CANCER, (1998), vol. 76, pages 250 - 258, XP002951123 DOI: http://dx.doi.org/10.1002/(SICI)1097-0215(19980413)76:2<250::AID-IJC13>3.0.CO;2-G | [Y] - GONG, J. ET AL., "Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity", J. IMMUNOL., (2000), vol. 165, pages 1705 - 1711, XP002171429 | [Y] - GONG, J. ET AL., "Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells", PROC. NATL. ACAD. SCI. USA, (20000314), vol. 97, no. 6, pages 2715 - 2718, XP002170124 DOI: http://dx.doi.org/10.1073/pnas.050587197 | Examination | - AHUJA S. ET AL., "Human dendritic cell (DC)-based anti-infeective therapy: engineering DCs to secrete functional IFN-gamma and IL-12", J. IMMUNOLOGY, US, (1998), vol. 161, pages 868 - 876 |